Erasca
compelling reproducible clinical efficacy across studies and doses melanoma patients | Erasca
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
18 of 41
Related slides by other companies
Immatics
Investor Presentation
November 2023
| Immatics
Warby Parker
Results
November 2023
we compelling and consistent sales retention rates one bate months months months months | Warby Parker
AvePoint
Investor Presentation
March 2022
to non reconciliation | AvePoint
Chimerix
Mergers and Acquisitions
January 2021
compelling responses in recurrent mutant disease drives strong engagement by first patients ease coco using name | Chimerix
Other recent decks by Erasca
See all presentations (4 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
IPO
July 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io